216 related articles for article (PubMed ID: 29111864)
21. Mechanism of corneal permeation of L-valyl ester of acyclovir: targeting the oligopeptide transporter on the rabbit cornea.
Anand BS; Mitra AK
Pharm Res; 2002 Aug; 19(8):1194-202. PubMed ID: 12240946
[TBL] [Abstract][Full Text] [Related]
22. Comparison of liposome-encapsulated acyclovir with acyclovir ointment: ocular pharmacokinetics in rabbits.
Chetoni P; Rossi S; Burgalassi S; Monti D; Mariotti S; Saettone MF
J Ocul Pharmacol Ther; 2004 Apr; 20(2):169-77. PubMed ID: 15117573
[TBL] [Abstract][Full Text] [Related]
23. Hyaluronic-Coated Albumin Nanoparticles for the Non-Invasive Delivery of Apatinib in Diabetic Retinopathy.
Radwan SE; El-Kamel A; Zaki EI; Burgalassi S; Zucchetti E; El-Moslemany RM
Int J Nanomedicine; 2021; 16():4481-4494. PubMed ID: 34239300
[TBL] [Abstract][Full Text] [Related]
24. Folic acid conjugated bovine serum albumin: An efficient smart and tumor targeted biomacromolecule for inhibition folate receptor positive cancer cells.
Nosrati H; Abbasi R; Charmi J; Rakhshbahar A; Aliakbarzadeh F; Danafar H; Davaran S
Int J Biol Macromol; 2018 Oct; 117():1125-1132. PubMed ID: 29885392
[TBL] [Abstract][Full Text] [Related]
25. Synergistic penetration of ethosomes and lipophilic prodrug on the transdermal delivery of acyclovir.
Zhou Y; Wei YH; Zhang GQ; Wu XA
Arch Pharm Res; 2010 Apr; 33(4):567-74. PubMed ID: 20422366
[TBL] [Abstract][Full Text] [Related]
26. Acyclovir Solid Lipid Nanoparticles for Skin Drug Delivery: Fabrication, Characterization and In vitro Study.
Bhupinder K; Newton MJ
Recent Pat Drug Deliv Formul; 2017; 11(2):132-146. PubMed ID: 28124592
[TBL] [Abstract][Full Text] [Related]
27. Functional expression of a sodium dependent nucleoside transporter on rabbit cornea: Role in corneal permeation of acyclovir and idoxuridine.
Majumdar S; Gunda S; Mitra A
Curr Eye Res; 2003; 26(3-4):175-83. PubMed ID: 12815545
[TBL] [Abstract][Full Text] [Related]
28. Topical delivery of different acyclovir palmitate liposome formulations through rat skin in vitro.
Liu H; Pan WS; Tang R; Luo SD
Pharmazie; 2004 Mar; 59(3):203-6. PubMed ID: 15074594
[TBL] [Abstract][Full Text] [Related]
29. Galactose decorated PLGA nanoparticles for hepatic delivery of acyclovir.
Gupta S; Agarwal A; Gupta NK; Saraogi G; Agrawal H; Agrawal GP
Drug Dev Ind Pharm; 2013 Dec; 39(12):1866-73. PubMed ID: 22397550
[TBL] [Abstract][Full Text] [Related]
30. Enhanced antiviral activity of Acyclovir loaded into beta-cyclodextrin-poly(4-acryloylmorpholine) conjugate nanoparticles.
Cavalli R; Donalisio M; Civra A; Ferruti P; Ranucci E; Trotta F; Lembo D
J Control Release; 2009 Jul; 137(2):116-22. PubMed ID: 19361545
[TBL] [Abstract][Full Text] [Related]
31. Preparation, characterization and cytotoxic evaluation of bovine serum albumin nanoparticles encapsulating 5-methylmellein: A secondary metabolite isolated from Xylaria psidii.
Arora D; Kumar A; Gupta P; Chashoo G; Jaglan S
Bioorg Med Chem Lett; 2017 Dec; 27(23):5126-5130. PubMed ID: 29100800
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and characterization of folate decorated albumin bio-conjugate nanoparticles loaded with a synthetic curcumin difluorinated analogue.
Gawde KA; Kesharwani P; Sau S; Sarkar FH; Padhye S; Kashaw SK; Iyer AK
J Colloid Interface Sci; 2017 Jun; 496():290-299. PubMed ID: 28236692
[TBL] [Abstract][Full Text] [Related]
33. Bovine serum albumin nanoparticles for delivery of tacrolimus to reduce its kidney uptake and functional nephrotoxicity.
Zhao L; Zhou Y; Gao Y; Ma S; Zhang C; Li J; Wang D; Li X; Li C; Liu Y; Li X
Int J Pharm; 2015 Apr; 483(1-2):180-7. PubMed ID: 25681723
[TBL] [Abstract][Full Text] [Related]
34. Nano and microparticulate chitosan-based systems for antiviral topical delivery.
Calderón L; Harris R; Cordoba-Diaz M; Elorza M; Elorza B; Lenoir J; Adriaens E; Remon JP; Heras A; Cordoba-Diaz D
Eur J Pharm Sci; 2013 Jan; 48(1-2):216-22. PubMed ID: 23159663
[TBL] [Abstract][Full Text] [Related]
35. [Preparation of valaciclovir loaded bovine serum albumin nanoparticles surface-modified with glycyrrhizin and its characteristics of targeting to liver].
Mao S; Hou S; Zhang L; Wei D; Zhang J; Qiao X; He R
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Aug; 21(4):570-4. PubMed ID: 15357434
[TBL] [Abstract][Full Text] [Related]
36. Improved permeability of acyclovir: optimization of mucoadhesive liposomes using the phospholipid vesicle-based permeation assay.
Naderkhani E; Erber A; Škalko-Basnet N; Flaten GE
J Pharm Sci; 2014 Feb; 103(2):661-8. PubMed ID: 24395733
[TBL] [Abstract][Full Text] [Related]
37. In situ preparation of water-soluble ginsenoside Rh2-entrapped bovine serum albumin nanoparticles: in vitro cytocompatibility studies.
Singh P; Kim YJ; Singh H; Ahn S; Castro-Aceituno V; Yang DC
Int J Nanomedicine; 2017; 12():4073-4084. PubMed ID: 28603419
[TBL] [Abstract][Full Text] [Related]
38. Preparation, characterization and pharmacokinetic studies of tacrolimus-dimethyl-β-cyclodextrin inclusion complex-loaded albumin nanoparticles.
Gao S; Sun J; Fu D; Zhao H; Lan M; Gao F
Int J Pharm; 2012 May; 427(2):410-6. PubMed ID: 22326299
[TBL] [Abstract][Full Text] [Related]
39. Preparation, characterization and biodistribution of the lactone form of 10-hydroxycamptothecin (HCPT)-loaded bovine serum albumin (BSA) nanoparticles.
Yang L; Cui F; Cun D; Tao A; Shi K; Lin W
Int J Pharm; 2007 Aug; 340(1-2):163-72. PubMed ID: 17482779
[TBL] [Abstract][Full Text] [Related]
40. Development of mucoadhesive microspheres of acyclovir with enhanced bioavailability.
Tao Y; Lu Y; Sun Y; Gu B; Lu W; Pan J
Int J Pharm; 2009 Aug; 378(1-2):30-6. PubMed ID: 19465102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
